NEW YORK, NY / ACCESSWIRE / May 27, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

LBRT Shareholders Click Here: https://www.zlk.com/pslra-1/liberty-oilfield-services-inc-loss-form?prid=6931&wire=1
DNK Shareholders Click Here: https://www.zlk.com/pslra-1/phoenix-tree-holdings-limited-loss-form?prid=6931&wire=1
WORX Shareholders Click Here: https://www.zlk.com/pslra-1/scworx-corp-loss-submission-form?prid=6931&wire=1

* ADDITIONAL INFORMATION BELOW *

Liberty Oilfield Services, Inc. (NYSE:LBRT)

The LBRT Lawsuit is on behalf of investors who purchased securities pursuant and/or traceable to the documents issued in connection with the Company's January 2018 initial public offering.
Lead Plaintiff Deadline : June 2, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/liberty-oilfield-services-inc-loss-form?prid=6931&wire=1

According to the filed complaint, (1) there was an oversupply in the hydraulic fracturing services market; (2) the Company's pricing power was weak; (3) Liberty's services were not increasing, and its competition was not decreasing; and (4) as a result, Defendants' statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Phoenix Tree Holdings Limited (NYSE:DNK)

Investors affected purchased American Depositary Shares ("ADS") of Phoenix pursuant and/or traceable to prospectuses and registration statements issued in connection with the Company's January 2020 initial public offering
Lead Plaintiff Deadline: June 26, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/phoenix-tree-holdings-limited-loss-form?prid=6931&wire=1

According to the filed complaint, the documents Phoenix Tree issued in connection with its initial public offering ("IPO") omitted or otherwise misrepresented the nature and level of renter complaints the Company had received before and as of the IPO, as well as the demand in the Chinese residential rental market and the Company's exposure to significant adverse developments resulting from the onset of the coronavirus in China – particularly in Wuhan – at the time of the IPO. After the IPO, reports emerged, indicating that Phoenix was experiencing ongoing problems due to the coronavirus, which was causing financial and other harm to tenants.

SCWorx Corp. (NASDAQ: WORX)

WORX Lawsuit on behalf of: investors who purchased April 13, 2020 – April 17, 2020
Lead Plaintiff Deadline: June 29, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/scworx-corp-loss-submission-form?prid=6931&wire=1

According to the filed complaint, during the class period, SCWorx Corp. made materially false and/or misleading statements and/or failed to disclose that: (1) SCWorx's supplier for COVID-19 tests had previously misrepresented its operations; (2) SCWorx's buyer was a small company that was unlikely to adequately support the purported volume of orders for COVID-19 tests; (3) as a result, the Company's purchase order for COVID-19 tests had been overstated or entirely fabricated; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington, D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
http://www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 591653

NEW YORK, NY / ACCESSWIRE / May 27, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

Gossamer Bio, Inc. (NASDAQ:GOSS)

CONTACT JAKUBOWITZ ABOUT GOSS:
https://claimyourloss.com/securities/gossamer-bio-inc-loss-submission-form/?id=6930&from=1

The GOSS lawsuit is on behalf of investors who purchased GOSS common stock between February 8, 2019 and December 13, 2019 and/or who acquired Gossamer shares pursuant or traceable to Gossamer's documents issued in connection with its February 8, 2019 initial public offering.

Lead Plaintiff Deadline: June 2, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose: (1) the reasons for Gossamer's GB001 trial failures; (2) the purported clinical validation of Novartis' oral DP2 antagonist; and (3) that, as a result of the foregoing, Defendants' public statements were materially false and misleading at all relevant times.

Groupon, Inc. (NASDAQ:GRPN)

CONTACT JAKUBOWITZ ABOUT GRPN:
https://claimyourloss.com/securities/groupon-inc-loss-submission-form/?id=6930&from=1

Class Period: November 4, 2019 – February 18, 2020

Lead Plaintiff Deadline: June 29, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company was experiencing fewer customer engagements in its Goods category; (2) Groupon relied on its Goods category to drive its sales, especially during the holiday season; (3) as a result of the foregoing, the Company was likely to experience reduced sales; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

CytomX Therapeutics, Inc. (NASDAQ:CTMX)

CONTACT JAKUBOWITZ ABOUT CTMX:
https://claimyourloss.com/securities/cytomx-therapeutics-inc-loss-submission-form/?id=6930&from=1

Class Period: May 17, 2018 – May 13, 2020

Lead Plaintiff Deadline: July 20, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) CytomX had downplayed issues with CX-072's efficacy observed in the PROCLAIM-CX-072 clinical program; (ii) CytomX had similarly downplayed issues with CX-2009's efficacy and safety observed in the PROCLAIM-CX-2009 clinical program; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887

SOURCE: Jakubowitz Law

ReleaseID: 591652

NEW YORK, NY / ACCESSWIRE / May 27, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Fifth Third Bancorp ("Fifth Third" or "the Company") (NASDAQ:FITB) on behalf of shareholders who purchased Fifth Third securities between February 26, 2016, and March 6, 2020, inclusive (the ''Class Period''). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/fitb.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that throughout the Class Period, defendants made false and misleading and/or failed to disclose that: (1) as a result of Fifth Third Bank's aggressive incentive policies to promote its cross-sell strategy, Fifth Third Bank employees engaged in unauthorized conduct with customer accounts; (2) since at least 2008, Fifth Third Bank, and by extension, Fifth Third, was aware of such unauthorized conduct and, thus, that it was violating relevant regulations and laws aimed at protecting its consumers; (3) Fifth Third failed to properly implement and monitor its cross-sell program, detect and stop misconduct, and identify and remediate harmed consumers; (4) all the foregoing subjected the Company to a foreseeable risk of heightened regulatory scrutiny or investigation; (5) Fifth Third's revenues were in part the product of unlawful conduct and thus unsustainable; and (6) as a result, the Company's public statements were materially false and misleading at all relevant times.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/fitb or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Fifth Third you have until June 8, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 591215

All Proposed Resolutions Approved

PLANEGG/MUNICH, GERMANY / ACCESSWIRE / May 27, 2020 / MorphoSys AG (FSE:MOR; Prime Standard Segment, MDAX & TecDAX; NASDAQ:MOR) announced today that its shareholders approved all resolutions proposed by the Company's Management and Supervisory Boards at the Company's virtual Annual General Meeting which took place on Wednesday, May 27, 2020, including:

The discharge of the members of the Management and Supervisory Boards with respect to the 2019 financial year
The appointment of PricewaterhouseCoopers AG as auditor for the 2020 financial year
Resolution on the reduction of the number of Supervisory Board members
Resolution on the election of Supervisory Board members
Resolution on an amendment to the Articles of Association with regard to the prerequisites for participation in the Annual General Meeting
Resolution on an amendment to the Articles of Association with regard to conducting the Annual General Meeting
Resolution on the adjustment of the Supervisory Board remuneration
Resolution on the cancellation of Authorized Capital 2017-I and the creation of new Authorized Capital 2020-I with the option to exclude statutory subscription rights
Resolution on the creation of Conditional Capital 2020-I and the authorization to grant subscription rights to members of the Management Board of MorphoSys AG, members of the executive management bodies of affiliated companies in Germany and abroad and selected employees of MorphoSys AG and affiliated companies in Germany and abroad (Stock Option Plan 2020)

At the 2020 virtual Annual General Meeting of MorphoSys AG, 60.28 % of the current share capital were represented. The Company made use of the option provided by the German legislator in view of the coronavirus pandemic to conduct ordinary annual general meetings in 2020 without the physical presence of shareholders or their proxies. Via a password-protected web service, registered shareholders could, among other things, visually and audibly follow the entire Annual General Meeting, exercise their voting rights and submit questions.

Effective April 11, 2020, Supervisory Board member Dr. Frank Morich resigned from the Supervisory Board of MorphoSys AG at his own request. He had been appointed to the Supervisory Board in May 2015. By resolution of today's Annual General Meeting, the size of the Supervisory Board was reduced to six members.

"On behalf of my colleagues of the Supervisory Board I would like to thank Dr. Frank Morich for his commitment and invaluable support over many years and wish him every success in the future," said Marc Cluzel, M.D., Chairman of the Supervisory Board of MorphoSys AG.

"I would like to thank our shareholders for their continued support and trust, also on behalf of my colleagues on the Management Board," commented Jean-Paul Kress, M.D., Chief Executive Officer of MorphoSys AG.

More information on the Company's Annual General Meeting including the voting results on all agenda items can be found at www.morphosys.com/agm.

About MorphoSys

MorphoSys (FSE & NASDAQ: MOR) is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of exceptional, innovative therapies for patients suffering from serious diseases. The focus is on cancer. Based on its leading expertise in antibody, protein and peptide technologies, MorphoSys, together with its partners, has developed and contributed to the development of more than 100 product candidates, 27 of which are currently in clinical development. In 2017, Tremfya(R), marketed by Janssen for the treatment of plaque psoriasis, became the first drug based on MorphoSys' antibody technology to receive regulatory approval. MorphoSys most advanced proprietary product candidate, tafasitamab (MOR208), is in late-stage clinical development for the treatment of patients with relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL). Headquartered near Munich, Germany, the MorphoSys group, including the fully owned U.S. subsidiary MorphoSys US Inc., has ~500 employees. More information at www.morphosys.com

HuCAL(R), HuCAL GOLD(R), HuCAL PLATINUM(R), CysDisplay(R), RapMAT(R), arYla(R), Ylanthia(R), 100 billion high potentials(R), Slonomics(R), Lanthio Pharma(R), LanthioPep(R) and ENFORCER(R) are trademarks of the MorphoSys Group. Tremfya(R) is a trademark of Janssen Biotech, Inc. XmAb(R) is a trademark of Xencor, Inc.

MorphoSys forward looking statements

This communication contains certain forward-looking statements concerning the MorphoSys group of companies, including the expectations regarding the licensing agreements for tafasitamab, the further clinical development of tafasitamab, interactions with regulatory authorities and expectations regarding regulatory filings and possible approvals for tafasitamab as well as the potential future commercialization of tafasitamab. The forward-looking statements contained herein represent the judgment of MorphoSys as of the date of this release and involve known and unknown risks and uncertainties, which might cause the actual results, financial condition and liquidity, performance or achievements of MorphoSys, or industry results, to be materially different from any historic or future results, financial conditions and liquidity, performance or achievements expressed or implied by such forward-looking statements. In addition, even if MorphoSys' results, performance, financial condition and liquidity, and the development of the industry in which it operates are consistent with such forward-looking statements, they may not be predictive of results or developments in future periods. Among the factors that may result in differences are MorphoSys' expectations regarding the licensing agreements for tafasitamab, the further clinical development of tafasitamab, interactions with regulatory authorities and expectations regarding regulatory filings and possible approvals for tafasitamab as well as the potential future commercialization of tafasitamab, MorphoSys' reliance on collaborations with third parties, estimating the commercial potential of its development programs and other risks indicated in the risk factors included in MorphoSys' Annual Report on Form 20-F and other filings with the US Securities and Exchange Commission. Given these uncertainties, the reader is advised not to place any undue reliance on such forward-looking statements. These forward-looking statements speak only as of the date of publication of this document. MorphoSys expressly disclaims any obligation to update any such forward-looking statements in this document to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements, unless specifically required by law or regulation.

For more information, please contact:

MorphoSys

Investor Contact:

Dr. Julia Neugebauer
Director Corporate Communications & IR
Tel: +49 (0) 89 / 899 27-179
Julia.Neugebauer@morphosys.com

Media Contacts:

Dr. Anca Alexandru
Associate Director Corporate Communications & IR
Tel: +49 (0) 89 / 899 27-26738
Anca.Alexandru@morphosys.com

Dr. Verena Kupas
Associate Director Corporate Communications & IR
Tel: +49 (0) 89 / 899 27-26814
Verena.Kupas@morphosys.com

SOURCE: MorphoSys AG

ReleaseID: 591649

NEW YORK, NY / ACCESSWIRE / May 27, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against VMware, Inc. ("VMware " or "the Company") (NYSE:VMW) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired VMware securities between March 30, 2019 and February 27, 2020, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/vmw.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements that: (1) VMware's reporting with respect to its backlog of unfilled orders was not in compliance with all relevant accounting and disclosure requirements; (2) the foregoing subjected the Company to a foreseeable risk of heightened regulatory scrutiny and/or investigation; and (3) as a result, the Company's public statements were materially false and misleading at all relevant times.

On February 27, 2019, VMware disclosed a U.S. Securities and Exchange Commission ("SEC") investigation into its backlog of unfilled orders. Specifically, VMware advised investors that the SEC requested a series of documents and information related to the Company's backlog and associated accounting and disclosures in December 2019. On this news, VMware's stock price fell $15.11 per share, or 11.14%, to close at $120.52 per share on February 28, 2020.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/vmw or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in VMware you have until June 1, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz and Grossman, LLC

ReleaseID: 591159

NEW YORK, NY / ACCESSWIRE / May 27, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Bed Bath & Beyond Inc. (NASDAQ:BBBY)

Investors Affected : October 2, 2019 – February 11, 2020

A class action has commenced on behalf of certain shareholders in Bed Bath & Beyond Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) due to "aggressive disposition of inventory," the Company lacked sufficient inventory in key categories to support holiday sales; (2) the Company's internal control over inventory levels and financial reporting was not effective; (3) as a result of the foregoing, the Company was likely to experience reduced sales; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/bed-bath-beyond-inc-loss-submission-form/?id=6929&from=1

Hallmark Financial Services, Inc. (NASDAQ:HALL)

Investors Affected : March 5, 2019 – March 17, 2020

A class action has commenced on behalf of certain shareholders in Hallmark Financial Services, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company lacked effective internal controls over accounting and financial reporting related to reserves for unpaid losses; (2) the Company improperly accounted for reserve for unpaid losses and loss adjustment expenses related to its Binding Primary Commercial Auto business; (3) as a result, Hallmark Financial would be forced to report a $63.8 million loss development for prior underwriting years; (4) as a result, Hallmark Financial would exit from its Binding Primary Commercial Auto business; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/hallmark-financial-services-inc-loss-submission-form/?id=6929&from=1

Ryder System, Inc. (NYSE:R)

Investors Affected : July 23, 2015 – February 13, 2020

A class action has commenced on behalf of certain shareholders in Ryder System, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Ryder's financial results were inflated as a result of the Company's practice of overstating the residual values of the vehicles in its fleet; (2) there was no reasonable basis to believe that Ryder would sell its used vehicles for the amounts that it had assigned to them; (3) Ryder's residual values for its fleet of vehicles exceeded the expected future values that would be realized upon the sale of those vehicles; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/ryder-system-inc-loss-submission-form/?id=6929&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm

ReleaseID: 591648

NEW YORK, NY / ACCESSWIRE / May 27, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Golden Star Resources Ltd. ("Golden Star" or the Company") (NYSE:GSS) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Golden Star securities between February 20, 2019 and July 30, 2019, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/gss.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements that: (1) the Company had insufficient geological and geotechnical data in its Prestea mine; (2) the Company had experienced deficiencies in its operating practices and mining methods including inaccurate long hole drilling and blasting in its Prestea mine; (3) the Company did not have the mining flexibility and more measured resources to ensure higher reserve grade; (4) the Company had experienced increased tonnage at much lower grade where it had to supplement some of the production with oxide material; (5) the Company had excessive dilution which drove lower mining rates at the Prestea mine; and (6) as a result, defendants' public statements were materially false and/or misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/gss or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Golden Star you have until June 1, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz and Grossman, LLC

ReleaseID: 591156

LOS ANGELES, CA / ACCESSWIRE / May 27, 2020 / With more than 1,7 million confirmed cases and over 100.000 deaths, the US is by far the country who suffered the most from the ongoing coronavirus outbreak. The country has entered in lockdown, with social distancing rules being enforced. That means that numerous businesses were also closed and workers, fired. There are more than 40 million US citizens who lost their jobs.

Without a secure job, policyholders have a difficult time paying for essential insurance services, including auto coverage. To help them out, insurance companies have implemented certain payment plans, including pausing non-renewal cancellations or non-payment cancellations. Furthermore, most insurers have implemented premium refunds programs.

To find out more about available measures for cutting insurance costs and insurance companies' response to the crisis, visit https://compare-autoinsurance.org/car-insurance-companies-help-drivers-pass-through-these-times-of-financial-hardship-caused-by-the-coronavirus-pandemic

Fewer cars on the roads mean fewer accidents and claims. It was expected for insurance companies to provide support to stay-at-home drivers. Insurance companies have issued various support programs, including premium refunds, pausing policy cancelation for non-renewal or non-payment or various payment programs. The following measures were taken for April and May, and may also be available for June if the country remains on lockdown:

Allstate – The company said the average personal auto insurance customer will receive 15 percent back based on their monthly premiums in April and May. The money will automatically be deposited back on the bank or credit card used by the customers to pay premiums or applied as credits to the account.
Farmers Insurance – April auto insurance premiums are being cut by 25 percent. The reduction will be applied automatically on a customer's next bill or, if they are paid in full, a refund will be issued.
Geico – Geico is providing a 15 percent credit for auto and motorcycle policyholders at the time of their renewal from April 8 to Oct. 7. The credit will also apply to new policies purchased during this time. The company said it expects the credits to average about $150 per auto policy and $30 per motorcycle policy. Customers do not need to take any action to receive the credit, which will be applied when their policy renews.
The Hartford – A 15 percent payback will be given on two months' worth of premium for all customers with an active auto policy as of April 1.
Liberty Mutual – Personal auto insurance customers will receive a 15 percent refunds on two months of their auto premiums. The refunds will be made in the manner as the most recent customer payment or by check. Refunds will happen automatically in the coming weeks.
Progressive Insurance – Customers will receive a 20 percent credit for their April and May premiums. The credits will automatically be applied to their accounts in May and June.
Nationwide – Customers will receive a one-time premium refund of $50 per policy. Timing will vary by state.
State Farm – State Farm will be providing an average of a 25% policy credit. The company will give customers $2 billion in rebates for those who have auto insurance policies with the company from between March 20 to May 31. Credits will be automatically applied, with most arriving in June. Customers will receive an average of 25 percent of their premiums, depending on where they live.
USAA – Members with auto policies in effect as of March 31 will receive a 20 percent credit on two months of premiums.
Travelers – The company will refund 15% credit on April and May premiums to customers with personal auto policies in force any time between April 1 and May 31, 2020
Mercury – 15% savings for April and May 2020 All personal auto policyholders with an active policy are eligible No action needed and policyholders will receive money automatically.
Amica Mutual Insurance plans to refund 20% of April and May premiums.
American Family Insurance customers will receive a one-time refund of $50 per vehicle.
Auto-Owners Insurance is giving policyholders a 15% premium credit for April and May.
Chubb is providing a 35% credit for April and May premiums, plus potential additional discounts as the situation warrants.
Country Financial is giving a 15% refund for two months of premiums.
Erie Insurance is seeking approval to reduce premiums in the 12 states where it writes policies.
Hanover Insurance is providing 15% refunds for April and May premiums.
The Hartford Insurance is crediting their customers with 15% of their April and May premiums.
Metlife is crediting its auto insurance customers for 15% of their April and May premiums.
Safeco auto insurance customers will receive a 15% credit for two months of premiums
Travelers is providing a 15% credit on their April and May premiums

For additional info, money-saving tips and free car insurance quotes, visit https://compare-autoinsurance.org/

Compare-autoinsurance.org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc.

"Car insurance companies helped their clients by providing various refunds or support programs in April and May. The same measures are expected to be kept active in June" said Gurgu C, Project Manager of Internet Marketing Company.

CONTACT:

Company Name: Internet Marketing Company
Person for contact: Gurgu C
Phone Number: (818) 359-3898
Email: cgurgu@internetmarketingcompany.biz
Website: https://compare-autoinsurance.org/

SOURCE: Internet Marketing Company

ReleaseID: 591638